# Establishment of a Multidimensional Prediction Model for the Natural Course of VHL Disease-related Renal Cell Carcinoma

> **NCT06391879** · — · UNKNOWN · sponsor: **Peking University First Hospital** · enrollment: 300 (estimated)

## Conditions studied

- VHL Syndrome
- Renal Cell Carcinoma

## Interventions

- **GENETIC:** Single cell sequencing, whole genome and metabolomic sequencing

## Key facts

- **NCT ID:** NCT06391879
- **Lead sponsor:** Peking University First Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-09-08
- **Primary completion:** 2025-06-30
- **Final completion:** 2025-08-31
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2024-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06391879

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06391879, "Establishment of a Multidimensional Prediction Model for the Natural Course of VHL Disease-related Renal Cell Carcinoma". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06391879. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*